- Home
- PCVX vs BIRK Comparison
PCVX vs BIRK Comparison
Compare PCVX & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- BIRK
- Stock Information
- Founded
- PCVX 2013
- BIRK 1774
- Country
- PCVX United States
- BIRK United Kingdom
- Employees
- PCVX N/A
- BIRK N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- BIRK
- Sector
- PCVX Health Care
- BIRK
- Exchange
- PCVX Nasdaq
- BIRK Nasdaq
- Market Cap
- PCVX 13.2B
- BIRK 9.4B
- IPO Year
- PCVX 2020
- BIRK 2023
- Fundamental
- Price
- PCVX $78.14
- BIRK $56.47
- Analyst Decision
- PCVX Strong Buy
- BIRK Strong Buy
- Analyst Count
- PCVX 9
- BIRK 15
- Target Price
- PCVX $149.38
- BIRK $67.27
- AVG Volume (30 Days)
- PCVX 1.1M
- BIRK 1.6M
- Earning Date
- PCVX 02-25-2025
- BIRK 02-20-2025
- Dividend Yield
- PCVX N/A
- BIRK N/A
- EPS Growth
- PCVX N/A
- BIRK 148.78
- EPS
- PCVX N/A
- BIRK 1.14
- Revenue
- PCVX N/A
- BIRK $2,012,815,078.00
- Revenue This Year
- PCVX N/A
- BIRK $20.02
- Revenue Next Year
- PCVX N/A
- BIRK $17.04
- P/E Ratio
- PCVX N/A
- BIRK $49.64
- Revenue Growth
- PCVX N/A
- BIRK 20.96
- 52 Week Low
- PCVX $58.10
- BIRK $41.00
- 52 Week High
- PCVX $121.06
- BIRK $64.78
- Technical
- Relative Strength Index (RSI)
- PCVX 32.14
- BIRK 53.00
- Support Level
- PCVX $80.10
- BIRK $55.02
- Resistance Level
- PCVX $81.70
- BIRK $58.62
- Average True Range (ATR)
- PCVX 3.12
- BIRK 1.68
- MACD
- PCVX -0.13
- BIRK -0.51
- Stochastic Oscillator
- PCVX 5.68
- BIRK 23.77
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About BIRK Birkenstock Holding plc
Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. The company operates in four operating segments based on its regional hubs: Americas, Europe and APMA (Asia Pacific, Middle East and Africa). The company sells its products through two main channels: business-to-business (B2B) and direct-to-consumer (DTC).